Equipoise (Boldenone) protocol

Standard

Cycle

1.2–2.4 mL/week

300–600 mg/week · 1–2×/week

~300 mg/week is the floor to feel it. Run with a base testosterone.

Duration

16+ weeks, the long ester needs a long cycle to show full effect.

Phase	How often	Dose	Units	Notes
Cycle	1–2×/week	300–600 mg/week	1.2–2.4 mL/week	~300 mg/week is the floor to feel it. Run with a base testosterone.
Duration	–	–	–	16+ weeks, the long ester needs a long cycle to show full effect.

Volume column is for 250 mg/mL.

Cycle & timing

Cycle: 16+ weeks (long ester); pair with test.

Where: IM. Rotate. Sterile technique.

What to expect

Slow, steady lean gains, better pumps/endurance, and appetite over a long cycle. Not a dramatic mass builder, a quality/conditioning compound.

How much to buy

For 10mL → ~4 weeks at 600 mg/wk, a 16-week cycle needs ~4 vials:

~4

× 10mL vials

Men & women

Men: Slow-acting; notably raises red cells, watch hematocrit closely (donate blood if needed). Mild aromatization (monitor estradiol). Very long detection window.

Women: The long ester makes virilization especially dangerous, side effects persist for weeks and are hard to reverse. High virilization risk at any meaningful dose; generally avoided.

Storage

Room temp, dark. Warm to clear if cold-clouded.

Don't use if: Polycythemia / elevated hematocrit (EQ raises RBC strongly) · Cardiovascular disease · Prostate or breast cancer · Pregnancy (partner exposure)

Stop if you notice

Hematocrit >54% (or per clinician)
Chest pain, severe headache, neurologic/vision changes
Severe anxiety or cardiovascular symptoms

Side effects

Elevated hematocrit (the big one), increased appetite, mild estrogen rise, acne, hair loss (if predisposed), anxiety in some users. Generally fewer estrogenic sides than test.

Drug interactions

Anticoagulants: bleeding/clotting balance altered, monitor. Other RBC-raising agents: compounded polycythemia risk.

Labs

CBC (hematocrit), especially important with EQ. Lipids, estradiol, testosterone, PSA (age-appropriate), liver enzymes. Blood pressure. Out of range? Hematocrit >54% = blood too thick (donate or hold); high estradiol = manage it; a rising PSA = get the prostate checked.

What these labs mean →

Warnings

Pronounced high red-blood-cell count, clot/stroke risk; monitor hematocrit, may need blood donation. HPTA suppression, requires a base testosterone and a recovery plan. Adverse lipids and cardiovascular strain. Anxiety/restlessness reported by some users. Very long detection time and slow clearance.

Patient education

Controlled steroid, run with a base testosterone, not solo. Watch hematocrit closely, EQ's signature risk is thick blood. Long ester, be patient; cycles run 16+ weeks. Have a recovery/PCT plan.

These apply on top of the universal safety rules.

Pairs well with

Testosterone

mandatory base

Not with Trenbolone unless experienced

additive cardiovascular/RBC strain

Avoid with

High baseline hematocrit / polycythemia

Cardiovascular disease

Anxiety disorders

can worsen

Prostate/breast cancer

Pregnancy exposure

What it does

Controlled substance; suppresses natural testosterone, needs a base test and a PCT/recovery plan.

Boldenone undecylenate (Equipoise / EQ) is a testosterone derivative with a very long ester (~14-day half-life). It gives slow, quality lean-mass gains, marked appetite increase, and a strong rise in red blood cells (improved oxygen carrying/endurance). Aromatizes roughly half as much as testosterone. Always run alongside a base testosterone (it suppresses natural production).

Presentation

Vial	Form	Concentration	Note
10 mL	Oil solution (no reconstitution)	250 mg/mL	0.1 mL = 25 mg. Very long ester, effects build over weeks.

RBC

The standout effect, hematocrit can climb significantly; monitor and donate blood if needed.

References

researchdosing PubMed rxlist

From the guide, page 33.